-
KCNE4 Modulates Kv1.3 Blocker Pharmacology
2026-09-03
The reference study shows that KCNE4 changes Kv1.3 pharmacology by slowing intracellular Psora-4 inhibition without materially changing blocker affinity. This finding links leukocyte-specific channel architecture to assay kinetics and supports more realistic evaluation of Kv1.3 blockers in immune-cell research.
-
PDGF-BB, murine recombinant protein Guide
2026-09-02
A scenario-based guide to using PDGF-BB, murine recombinant protein in viability, proliferation, and cytotoxicity workflows. It explains how SKU P1048 supports assay design through defined activity, purity, endotoxin, reconstitution, and storage specifications.
-
Pyruvate Carboxylase, Ferroptosis, and NSCLC
2026-09-02
A 2026 Cancer Letters study identifies pyruvate carboxylase (PC) as a metabolic regulator of ferroptosis resistance in non-small cell lung cancer. The work connects ATP-dependent PC activity with AMPK suppression, AKT–mTOR-driven lipogenesis, and inhibition of the PPARα–ACSL4 pathway, while implicating DTX1 and USP51 as upstream regulators.
-
(Z)-4-Hydroxytamoxifen: A Mechanistic Assay Lens
2026-09-01
Explore (Z)-4-Hydroxytamoxifen as a high-affinity estrogen receptor probe and learn how nanoparticle research on redox biology can improve causal assay design. This article connects ER pharmacology, orthogonal readouts, delivery controls, and translational limitations without conflating distinct disease models.
-
AZD1480: Practical JAK2/STAT3 Assay Workflows
2026-09-01
Use AZD1480 to separate tumor-intrinsic JAK2/STAT3 survival signaling from broader immune effects after IDO1 blockade. This workflow covers cytokine stimulation, myeloma and solid-tumor assays, combination testing, and troubleshooting from stock preparation through pathway validation.
-
Tiamulin Metabolism Across Farm Animal Species
2026-08-31
This study mapped tiamulin biotransformation across rats, chickens, swine, goats, and cows using in vitro and in vivo models coupled with UHPLC–Q/TOF analysis. Its principal contribution is the identification of 26 metabolites, species-specific pathway differences, and candidate marker residues that can improve veterinary residue monitoring and food-safety assessment.
-
AZD1480 for Reliable JAK2/STAT3 Assays
2026-08-31
Learn how AZD1480 (SKU A4137) can help researchers distinguish JAK2/STAT3-driven survival from nonspecific assay variation in viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers mechanism, solvent control, compartment-resolved experiments, data interpretation, and practical product-selection criteria.
-
DOTAP Workflows for Precision Gene Delivery
2026-08-30
Learn how DOTAP supports reproducible DNA, RNA, and oligonucleotide delivery through tunable lipid–cargo complexation. A glaucoma nanomedicine study provides a practical framework for evaluating localized gene delivery while clarifying which findings are transferable to DOTAP-based formulations.
-
DOTAP and the Next Logic of Translational Delivery
2026-08-29
1,2-Dioleoyl-3-trimethylammonium-propane chloride, commonly known as DOTAP, is more than a conventional transfection reagent. Its cationic self-assembly offers a practical platform for testing how cargo, formulation, cell state, and biological compartment interact—while recent immune-metabolic nanomedicine research provides a strategic framework for translating delivery observations into mechanism-led development decisions.
-
Substance P Workflows for NK-1 Signaling
2026-08-28
Build reproducible Substance P experiments for pain transmission research, neuroimmune signaling, and NK-1 pathway studies with water-based preparation and assay-ready controls. A fluorescence-spectroscopy workflow from the reference study adds a practical strategy for recognizing and reducing matrix interference during exploratory quality control.
-
T7 RNA Polymerase Workflow for RNA Synthesis
2026-08-27
Build promoter-defined RNA workflows with T7 RNA Polymerase, from linearized plasmid and PCR templates to assay-ready transcripts. This guide connects practical transcription controls with the DDX21–NAT10 RNA biology reported in colorectal cancer research, while separating validated findings from proposed applications.
-
MK0787 vs Cefoperazone: 1982 Antibacterial Study
2026-08-27
This 1982 comparative study evaluated N-formimidoyl thienamycin (MK0787) against resistant clinical isolates and several contemporary β-lactam antibiotics, including Cefoperazone. Its main contribution was to combine broad-spectrum susceptibility testing with bactericidal and β-lactamase-related analyses, offering a useful framework for interpreting comparative antibacterial activity.
-
FAP-Sensitive Nanoparticles for Urinary Tumor Diagnosis
2026-08-26
Feng and colleagues developed magnetic iron oxide nanoparticles carrying a substrate–reporter peptide that converts fibroblast activation protein α activity in tumor tissue into a measurable urinary signal. In an esophageal squamous cell carcinoma xenograft model, the platform combined tumor biodistribution imaging with urine ELISA and achieved excellent separation of tumor-bearing and control mice, while remaining a preclinical proof of concept.
-
BH3 Mimetics Clear Senescent Breast Cancer Cells
2026-08-26
Shahbandi and colleagues showed that chemotherapy-induced senescent breast cancer cells can retain a therapeutically actionable dependence on BCL-XL or combined BCL-XL/MCL-1 signaling. Their study supports sequential chemotherapy and senolytic BH3-mimetic treatment as a strategy for reducing residual disease in TP53 wild-type breast cancer, while also identifying NOXA and apoptotic dependency as important response determinants.
-
CCT007093: Reading the PPM1D–p38 Circuit
2026-08-25
CCT007093 is a PPM1D inhibitor that reveals how phosphatase control shapes p38 signaling and cell fate. This article connects biochemical target engagement with cancer and kidney injury assays while emphasizing timing, controls, and interpretation.